| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Dimerix Limited (AU: DXB)
DXB Technical Analysis
4
| As on 8th Aug 2025 DXB STOCK Price closed @ 0.52 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.40 & Strong Buy for SHORT-TERM with Stoploss of 0.30 we also expect STOCK to react on Following IMPORTANT LEVELS. |
DXBSTOCK Price
| Open | 0.51 | Change | Price | % |
| High | 0.52 | 1 Day | 0.01 | 1.96 |
| Low | 0.50 | 1 Week | 0.04 | 8.33 |
| Close | 0.52 | 1 Month | -0.05 | -8.77 |
| Volume | 1243512 | 1 Year | 0.28 | 116.67 |
| 52 Week High 0.76 | 52 Week Low 0.20 | ||||
AU Australia Most Active Stocks
| PLS | 1.93 | 9.04% |
| WC8 | 0.18 | 5.88% |
| SYA | 0.03 | 50.00% |
| PRX | 0.00 | % |
| LTR | 0.84 | 0.00% |
| TMG | 0.10 | 11.11% |
| AMP | 1.88 | 7.43% |
| RML | 0.06 | % |
| NAE | 0.00 | % |
| VR1 | 0.04 | 0.00% |
AU Australia Top Gainers Stocks
AU Australia Top Losers Stocks
| DXB Daily Charts |
DXB Intraday Charts |
Whats New @ Bazaartrend |
DXB Free Analysis |
|
|
DXB Important Levels Intraday
| RESISTANCE | 0.56 |
| RESISTANCE | 0.55 |
| RESISTANCE | 0.54 |
| RESISTANCE | 0.53 |
| SUPPORT | 0.51 |
| SUPPORT | 0.50 |
| SUPPORT | 0.49 |
| SUPPORT | 0.48 |
DXB Forecast August 2025
| 4th UP Forecast | 0.69 |
| 3rd UP Forecast | 0.64 |
| 2nd UP Forecast | 0.6 |
| 1st UP Forecast | 0.57 |
| 1st DOWN Forecast | 0.47 |
| 2nd DOWN Forecast | 0.44 |
| 3rd DOWN Forecast | 0.4 |
| 4th DOWN Forecast | 0.35 |
DXB Weekly Forecast
| 4th UP Forecast | 0.69 |
| 3rd UP Forecast | 0.64 |
| 2nd UP Forecast | 0.60 |
| 1st UP Forecast | 0.57 |
| 1st DOWN Forecast | 0.47 |
| 2nd DOWN Forecast | 0.44 |
| 3rd DOWN Forecast | 0.40 |
| 4th DOWN Forecast | 0.35 |
DXB Forecast2025
| 4th UP Forecast | 1.64 |
| 3rd UP Forecast | 1.28 |
| 2nd UP Forecast | 1.06 |
| 1st UP Forecast | 0.84 |
| 1st DOWN Forecast | 0.2 |
| 2nd DOWN Forecast | -0.02 |
| 3rd DOWN Forecast | -0.24 |
| 4th DOWN Forecast | -0.6 |
Dimerix Limited ( AU Australia Symbol : DXB )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
DXB Business Profile
Dimerix Limited, a clinical-stage biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs. The company develops DMX-200 that is in two Phase 3 clinical trials for COVID respiratory complications; DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; and DMX-700 that is in pre-clinical development for chronic obstructive pulmonary disease. The company was founded in 2004 and is headquartered in Fitzroy, Australia. Address: 425 Smith Street, Fitzroy, VIC, Australia, 3065
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service